J.T. Greene

The BTK Inhibitor ARQ 531 Targets Ibrutinib-Resistant CLL and Richter Transformation

Sean D. Reiff, Rose Mantel, Lisa L. Smith et al. · Cancer Discovery · 2018 · 170 citations · Full text

Medicine, Oncology, Pharmacology +17

IGF1R- and ROR1-Specific CAR T Cells as a Potential Therapy for High Risk Sarcomas

Xin Huang, Haein Park, J.T. Greene et al. · PLoS ONE · 2015 · 108 citations · Full text

Life Sciences, Immunology, Oncology +17

PI3K p110δ inactivation antagonizes chronic lymphocytic leukemia and reverses T cell immune suppression

Shuai Dong, Bonnie K. Harrington, Eileen Hu et al. · Journal of Clinical Investigation · 2018 · 52 citations · Full text

Life Sciences, Oncology, Pharmacology +17

Novel role of prostate apoptosis response-4 tumor suppressor in B-cell chronic lymphocytic leukemia

Mary K. McKenna, Sunil K. Noothi, Sara S. Alhakeem et al. · Blood · 2018 · 26 citations · Full text

Life Sciences, Cancer Biology, Oncology +9

A dominant function of LynB kinase in preventing autoimmunity

Ben F. Brian, Monica L. Sauer, J.T. Greene et al. · Science Advances · 2022 · 16 citations · Full text

Life Sciences, Genetics, Immunology +17